Acta Psychiatr Scand

1. BRAILLON A
   Mortality Gap for People With Schizophrenia Spectrum Disorders: An Elephant in the Room?
   Acta Psychiatr Scand. 2026 Jan 19. doi: 10.1111/acps.70070.
   

   >> Share

   
   

   
   Compr Psychiatry

2. ADRIAN Q, Cohen RF, Plasse J, Chereau-Boudet I, et al
   Machine learning analysis of clinical, psychological and sociodemographic factors predicting mental well-being in patients with severe mental illness: Insights from the French REHABase cohort.
   Compr Psychiatry. 2026;145:152651.
   

   >> Share

   
   

   
   Mol Psychiatry

3. DE SIMONE G, De Prisco M, Oliva V, Vellucci L, et al
   Molecular and topographic mapping of antipsychotic effects: a meta-analysis of postsynaptic density proteins in animal models with translational implications.
   Mol Psychiatry. 2026;31:1142-1155.
   

   >> Share

   
   

   
   Nature

4. BIGDELI TB, Chatzinakos C, Bendl J, Barr PB, et al
   Biological insights into schizophrenia from ancestrally diverse populations.
   Nature. 2026 Jan 21. doi: 10.1038/s41586-025-10000.
   

   >> Share

   
   

   
   Neuropsychopharmacology

5. HE Z, He W, Chen Z, Wei W, et al
   Intrinsic connectivity patterns of striatal subfields predict individual dimensions of psychopathology and are associated with cholinergic and serotonergic neurotransmission in schizophrenia.
   Neuropsychopharmacology. 2026 Jan 17. doi: 10.1038/s41386-026-02354.
   

   >> Share

   
   

   
   Psychiatry Res

6. SCHOCK GV, Kittleson AR, Halverson AS, Liu J, et al
   Social networks and symptomatology in recently hospitalized individuals with schizophrenia-spectrum disorders: A six-month longitudinal study.
   Psychiatry Res. 2026;358:116960.
   

   >> Share

   
   
7. LIN CH, Chiang CL, Yu DY, Horio H, et al
   Clinical remission, functional recovery, and employment in early-phase schizophrenia treated with paliperidone palmitate: An 18-month longitudinal Asia-Pacific study.
   Psychiatry Res. 2026;358:116955.
   

   >> Share

   
   

   
   Schizophr Res

8. WANG LC, Lu AK, Zhu ZH, Hou WL, et al
   Association between reduced plasma dopamine beta-hydroxylase levels and immediate memory impairment in first-episode drug-naive schizophrenia.
   Schizophr Res. 2026;289:94-99.
   

   >> Share

   
   
9. MASHAL MA, Chen CS, Ramsay IS, Vinogradov S, et al
   Letter to the editor: Enhancing cognitive control in schizophrenia with transcranial direct current stimulation and targeted cognitive training.
   Schizophr Res. 2026;289:89-93.
   

   >> Share

   
   
10. CHEN H, Xiang H, Zhang M, Wen Y, et al
    Antipsychotic-disease duration interaction on glymphatic function in first-episode schizophrenia: Evidence from DTI-ALPS.
    Schizophr Res. 2026;289:79-88.
    

    >> Share

    
    
11. SISMAN O, Onen S
    Prevalence and multidimensional impact of sarcopenia in schizophrenia: Associations with oxidative stress, functioning, and symptom severity.
    Schizophr Res. 2026;289:61-70.
    

    >> Share

    
    
12. CESSA R, Ghiani A, Cenk E, Bertamini M, et al
    Perceptual organization and its visual subcomponents in schizophrenia and schizotypy: A systematic review.
    Schizophr Res. 2026;289:46-60.
    

    >> Share

    
    
13. KUZO N, Gaspari D, Carpi F, Hiemke C, et al
    Pharmacokinetic correlates of clinical response in a retrospective naturalistic cohort of patients treated with long-acting injectable antipsychotics.
    Schizophr Res. 2026;288:38-46.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share